Back to Browse Journals » International Journal of General Medicine » Volume 6

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias

Authors El-Charabaty E, Saifan C, Abdallah M, Naboush A, Glass D, Azzi G, Azzi Y, Khan A, Baydoun H, Rondla C, Parekh N, El-Sayegh S

Received 19 April 2013

Accepted for publication 9 May 2013

Published 28 June 2013 Volume 2013:6 Pages 515—518


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Elie El-Charabaty, Chadi Saifan, Mokhtar Abdallah, Ali Naboush, Daniel Glass, Georges Azzi, Yorg Azzi, Ahsan Khan, Hassan Baydoun, Chetana Rondla, Ninad Parekh, Suzanne El-Sayegh

Department of Medicine, Staten Island University Hospital, Staten Island, NY, USA

Abstract: Several case reports have been written regarding the relationship between the use of proton pump inhibitors (PPI) and hypomagnesemia. Some of these reported cases have electrocardiogram abnormalities where electrolytes deficiencies were the contributing factor for these events. This study investigates the correlation between different arrhythmias and the use of PPI and hypomagnesaemia incidence. Four-hundred and twenty-one patients admitted to the critical care unit with unstable angina, non-ST elevation myocardial infarction, and ST-elevation myocardial infarction were included in this study. One-hundred and eighty-four patients (43.8%) received PPI and 237 patients (51.16%) did not, magnesium levels were low (<1.8 mg/dL) in 95 patients (22.5%), and 167 patients (39.6%) developed arrhythmias. The P-values for the regression coefficient association for the use of PPI and the level of magnesium were P = 1.31e-29 and P = 8e-102, respectively. The P-values indicate that there is a statistically significant association between the PPI use, magnesium levels, and the occurrence of cardiovascular events, with a strong correlation factor of 0.817. Patients receiving PPIs should be followed closely for magnesium deficiency, especially if they experience acute cardiovascular events, because this may contribute to worsening arrhythmias and further complications.

Keywords: electrolyte disturbances, medications side effects, cardiac arrhythmias

A Letter to the Editor has been received and published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Relationship between platelet count and hemodialysis membranes

Nasr R, Saifan C, Barakat I, Al Azzi Y, Naboush A, Saad M, El Sayegh S

International Journal of Nephrology and Renovascular Disease 2013, 6:143-147

Published Date: 14 August 2013

Warfarin-induced calciphylaxis: a case report and review of literature

Saifan C, Saad M, El-Charabaty E, El-Sayegh S

International Journal of General Medicine 2013, 6:665-669

Published Date: 9 August 2013

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study

Saifan C, El-Charabaty E, El-Sayegh S

Vascular Health and Risk Management 2013, 9:361-364

Published Date: 17 July 2013

Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis

Saifan C, El-Charabaty E, Kleiner M, El-Sayegh S

International Journal of Nephrology and Renovascular Disease 2013, 6:121-124

Published Date: 28 June 2013

Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements

Saifan C, Samarneh M, Shtaynberg N, Nasr R, El-Charabaty E, El-Sayegh S

International Journal of Nephrology and Renovascular Disease 2013, 6:89-93

Published Date: 5 June 2013

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010